Catalog Advanced Search
86 Results
-
Contains 7 Component(s), Includes Credits
This 1 hour module provides a comprehensive overview of fetal alcohol spectrum disorders (FASD), equipping learners to identify, diagnose, and manage FASD across the lifespan through evidence-based, trauma-informed, multidisciplinary care.
Fetal Alcohol Spectrum Disorder (FASD): Strategies for Diagnosis, Management, and Prevention
Online Module
Created By: American Society of Addiction Medicine
Created: September 2026
Overview
This educational module provides an overview of fetal alcohol spectrum disorders (FASD), integrating core science, clinical identification, and systems-based care. Learners will explore alcohol as a teratogen, the neurobiology and epidemiology of prenatal alcohol exposure, and the impact of stigma, bias, and mixed messaging on diagnosis. The module reviews the FASD spectrum, highlighting under-diagnosis and overlap with other developmental conditions, and equips participants to recognize key neurobehavioral and physical features. It outlines the multidisciplinary diagnostic process, including obtaining prenatal exposure histories, conducting developmental assessments, and considering differential diagnoses and polysubstance exposure. Evidence-based, trauma-informed management strategies and guidance on appropriate referrals are presented, along with the importance of diagnosis even without a cure. Finally, the module addresses FASD across the lifespan and emphasizes collaboration with families, schools, healthcare systems, and community resources, alongside key legal, ethical, and public health considerations.
The target audience for this activity includes all clinical healthcare professionals.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge and Interpersonal and Communication Skills, and Systems-based practice.
Learning Objectives
Upon completion, learners will be able to:
- Identify the neurobiology and epidemiology of prenatal alcohol exposure, definitions within the FASD spectrum, and the impact of stigma, bias, and mixed media messaging on awareness and diagnosis.
- Describe the neurobehavioral and physical characteristics of FASD, the multidisciplinary diagnostic process, challenges in assessment and diagnosis, and considerations for differential diagnosis.
- Explain the key elements of FASD diagnosis, including prenatal exposure history, developmental assessment, and screening for other substance exposures.
- Explain evidence-based interventions for individuals with FASD and when and how to make appropriate referrals for assessment or management.
- Explain how FASD presents and is managed across the lifespan, as well as the roles of pediatric medical homes, transition of care, school systems, and the criminal legal system.
- Identify key legal, ethical, and systems considerations in FASD care.
- Describe prevention and public health strategies related to FASD.
Registration
This education is made available for free to all learners through grant funding by the Substance Abuse and Mental Health Services Administration (SAMHSA). Funding for this initiative was made possible (in part) by grant number 1H79TI086771-03 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Cancellations
All cancellation requests must be made in writing to [email protected] within 90 days of registration. Automatic cancellations and notifications will be made for any course with a live-activity component that has been cancelled.
Registration Deadline: 08/30/2027
Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View Course to complete the on-demand module. Please note: Reaching the Finish and Exit page does not confirm course completion. Before proceeding to the post-test, verify that each section listed in the left-hand navigation menu displays a blue completion icon. If any section does not show a blue check mark/circle, return to that section and complete all required content.
- Click Complete Post Test to answer multiple choice questions. You will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
- Click Complete GPRA Survey to complete the SAMHSA GPRA Survey.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Complete Evaluation - Presenters to provide valuable presenter feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate.
- For Pharmacists ONLY: Complete the task entitled "Enter Pharmacist CPE Monitor Information (Required for Pharmacists)". Pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist CPE Monitor Information survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Daniel Alford, MD, MPH
Daniel P. Alford, MD, MPH, is a board-certified primary care physician at Boston Medical Center (BMC), where he specializes in managing opioid use disorders and safer opioid prescribing. He is also a professor of medicine and associate dean of continuing medical education at Boston University Chobanian & Avedisian School of Medicine and the director of the Clinical Addiction Research and Education (CARE) Unit at BMC. Dr. Alford has been recognized as a Champion of Change by the White House and has received the American Medical Association’s Award for Health Education, among other honors.Education (CARE) Unit at BMC. Dr. Alford has been recognized as a Champion of Change by the White House and has received the American Medical Association’s Award for Health Education, among other honors.
Julia Conkel Ziebell, PhD, LP
Julia Conkel Ziebell is the Senior Program Manager of Healthcare Initiatives at Proof Alliance. She leads the FASD Diagnostic Clinic, providing pediatric neuropsychological assessment to youth impacted by prenatal alcohol exposure. Dr. Conkel Ziebell has worked within the field of FASD assessment and diagnosis for 15 years, consulting with clinicians and healthcare systems throughout MN and nationally. She has provided extensive training on FASD diagnostic practices and served on a variety of state-appointed task forces and committees—most recently leading the review of FASD diagnostic guidelines in Minnesota. Dr. Conkel Ziebell received her Ph.D. in educational psychology from the University of Minnesota. She completed her predoctoral training in pediatric neuropsychology at the University of Minnesota Medical School and postdoctoral training at Canvas Health. In addition, she holds a clinical certification as an FASD trainer from the Great Lakes FASD Regional Training Center (University of Wisconsin).
Vincent Smith, MD, MPH
Dr. Vincent C. Smith, MD, MPH is Division Chief of Newborn Medicine at Boston Medical Center (BMC) and Professor of Pediatrics at Boston University Medical School. Dr. Smith is a graduate of Texas A&M University, Stanford University School of Medicine, and the Harvard School of Public Health. He trained in pediatrics at Children’s Hospital and Boston Medical Center in the Boston Combined Pediatric Residency Program. He then completed a fellowship in neonatal-perinatal medicine through the Harvard wide program, a collaboration of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Massachusetts General Hospital, and Boston Children’s Hospital. He also completed a fellowship in health services research at Children’s Hospital. Dr. Smith serves as the medical director for the American Academy of Pediatrics’ Fetal Alcohol Spectrum Disorders Program. He is a member of the Board of Directors of the National Perinatal Association. He is an active member of the Massachusetts Medical Society and Society for Pediatric Research. He is also a former member of the National Perinatal Association Board of Directors.Boston Combined Pediatric Residency Program. He then completed a fellowship in neonatal-perinatal medicine through the Harvard wide program, a collaboration of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Massachusetts General Hospital, and Boston Children’s Hospital. He also completed a fellowship in health services research at Children’s Hospital. Dr. Smith serves as the medical director for the American Academy of Pediatrics’ Fetal Alcohol Spectrum Disorders Program. He is a member of the Board of Directors of the National Perinatal Association. He is an active member of the Massachusetts Medical Society and Society for Pediatric Research. He is also a former member of the National Perinatal Association Board of Directors. In addition to parental NICU discharge readiness, his professional interests also include families affected by substance use and medical care for LGBTQIA+-headed families.Boston Combined Pediatric Residency Program. He then completed a fellowship in neonatal-perinatal medicine through the Harvard wide program, a collaboration of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Massachusetts General Hospital, and Boston Children’s Hospital. He also completed a fellowship in health services research at Children’s Hospital. Dr. Smith serves as the medical director for the American Academy of Pediatrics’ Fetal Alcohol Spectrum Disorders Program. He is a member of the Board of Directors of the National Perinatal Association. He is an active member of the Massachusetts Medical Society and Society for Pediatric Research. He is also a former member of the National Perinatal Association Board of DirectorsBoston Combined Pediatric Residency Program. He then completed a fellowship in neonatal-perinatal medicine through the Harvard wide program, a collaboration of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Massachusetts General Hospital, and Boston Children’s Hospital. He also completed a fellowship in health services research at Children’s Hospital. Dr. Smith serves as the medical director for the American Academy of Pediatrics’ Fetal Alcohol Spectrum Disorders Program. He is a member of the Board of Directors of the National Perinatal Association. He is an active member of the Massachusetts Medical Society and Society for Pediatric Research. He is also a former member of the National Perinatal Association Board of DirectorsBoston Combined Pediatric Residency Program. He then completed a fellowship in neonatal-perinatal medicine through the Harvard wide program, a collaboration of Beth Israel Deaconess Medical Center, Brigham and Women’s Hospital, Massachusetts General Hospital, and Boston Children’s Hospital. He also completed a fellowship in health services research at Children’s Hospital. Dr. Smith serves as the medical director for the American Academy of Pediatrics’ Fetal Alcohol Spectrum Disorders Program. He is a member of the Board of Directors of the National Perinatal Association. He is an active member of the Massachusetts Medical Society and Society for Pediatric Research. He is also a former member of the National Perinatal Association Board of Directors
Accreditation & Credits
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
- Physicians: 1.0 Credits
- Nurses & NPs: 1.0 Nursing Contact Hours
- PAs: 1.0 Credits
- Pharmacists: 1.0 Credits
- Social Workers: 1.0 Credits
- Interprofessional Continuing Education: 1.0 Credits
- Certified Counselors: 1.0 NBCC Contact Hour
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
- NAADAC: 1.0 CE Credits
Maintenance of Certification (MOC)/Continuing Certification Program (CCP)
This activity is designed to meet the requirements for MOC/CCP for several primary physician boards and for state licensing CME requirements. MOC Credit is only reported and designated for ABA, ABP, ABIM, and ABS. By completing the online credit application and evaluation, the learner permits ASAM to report credits to the appropriate Board. Learn more.
- ABA MOCA 2.0®*: 1.0 Lifelong Learning
- ABIM MOC Points: 1.0 Medical Knowledge | 1.0 Patient Safety
- ABP MOC: 1.0 Lifelong Learning & Self-Assessment
- ABS Continuing Certification: 1.0 Accredited CME
Additionally, this activity has been designed to satisfy the requirements of the following primary physician board certification requirements. Please confirm with your individual Board.
- American Board of Preventative Medicine (ABPM)
- American Board of Psychiatry and Neurology (ABPN)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225.
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205.
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-0227.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
See the attached pdf for a list of disclosures.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 7 Component(s), Includes Credits
This five-video interactive series equips physicians with practical skills to address unhealthy alcohol use as part of routine patient care, with a focus on its impact on chronic health conditions. Through realistic patient scenarios and guided practice, learners will strengthen their ability to screen for alcohol use, apply motivational interviewing techniques, and support behavior change and treatment when appropriate.
Alcohol Use and Chronic Health Conditions
Interactive Video Series
Created by: the American Society of Addiction Medicine (ASAM) and the American College of Physicians (ACP)
Created: September 2026
Overview
This five-video interactive series helps healthcare professionals build practical skills for discussing unhealthy alcohol use with patients and integrating alcohol-related care into routine clinical practice. Through realistic patient scenarios and interactive elements, the series demonstrates how to screen for alcohol use, discuss its impact on chronic disease outcomes, and engage patients in meaningful conversations about behavior change and treatment options when appropriate. Together, the videos provide a structured approach to recognizing alcohol-related risk, connecting alcohol use to chronic disease management, and utilizing motivational interviewing.
The target audience for this introductory level activity includes: All healthcare professionals, particularly those working in primary care and family medicine.
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Interpersonal and Communication Skills.
Learning Objectives
Upon completion, learners will be able to:
- Incorporate and interpret routine screening for alcohol use into everyday clinical practice.
- Use brief motivational interviewing strategies effectively.
- Explain how alcohol use can affect chronic conditions and overall health outcomes.
- Discuss next-step care options, including behavior change strategies and medications for alcohol use disorder.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View Video #1 to watch the first video in the series. Once finished, click View Video #2 and proceed to watch all five videos.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Alyssa Peterkin, MD
Hospitalist
Boston Medical Center
Alyssa Peterkin, MD is an Instructor of Medicine Boston University School of Medicine and an internist at Boston Medical Center. Currently, she also serves as an associate program director for Grayken Addiction Medicine fellowship. She spends her clinical time working as a hospitalist, attending on the inpatient addiction consultation service and working in the substance use disorder urgent care. Her interests include educating learners at all levels and expanding access to addiction treatment.
No Relevant Financial Disclosures.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 60-minute training explores how telemedicine can expand access to medications for alcohol use disorder (MAUD), particularly in rural communities, by using real-world cases to demonstrate patient selection, engagement strategies, and practical approaches for integrating virtual AUD treatment into clinical care.
Telemedicine and Medications for Alcohol Use Disorder
Host: American Academy of Addiction Psychiatry
Recorded: September 9, 2026
Enduring TrainingOverview
This training examines how telemedicine can help address the treatment gap for alcohol use disorder (AUD). Participants will learn how telehealth can expand access to medications for alcohol use disorder (MAUD), particularly for patients in rural areas and communities where transportation challenges and geographic distance can limit access to care. Using real-world patient cases, the presenter discusses which individuals are best suited for telemedicine-based treatment, how virtual care can enhance patient engagement and continuity of care, and practical strategies for integrating telemedicine and MAUD into everyday clinical practice.
The target audience for this intermediate level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Discuss the benefits of telemedicine for MAUD.
- Determine which patients are appropriate for telemedicine.
- Explain how to integrate telemedicine for MAUD in to your own practice.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Gregory Jaffe, MD, MSEd
Assistant Professor of Family Medicine
Jefferson Health, Philadelphia
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 75-minute training examines the two-way relationship between sleep and alcohol use, helping participants recognize and treat sleep disturbances in individuals with alcohol use disorder through evidence-based behavioral and medication approaches to support recovery and overall well-being.
The Impact of Alcohol Use Disorder on Sleep Health
Host: Addiction Technology Transfer Center
Recorded: August 26, 2026
Enduring TrainingOverview
This training explores the complex, bidirectional relationship between sleep and alcohol use, highlighting how sleep problems can contribute to alcohol misuse and recovery challenges. Participants will examine the prevalence and impact of insomnia and other sleep disturbances in AUD, review the evidence supporting cognitive behavioral and pharmacological treatment approaches, and discuss practical strategies for addressing co-occurring sleep and alcohol-related concerns. Learners will be better equipped to recognize sleep-related issues in this population and identify effective treatment options to support recovery and overall well-being.
The target audience for this intermediate level activity includes: All healthcare professionals.
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Characterize sleep disturbances among those who use alcohol.
- Describe associations between sleep and alcohol use.
- Discuss treatment options for those with comorbid insomnia and alcohol use disorder.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Mary Beth Miller, PhD
Associate Professor, University of Missouri
Diplomate of Behavioral Sleep Medicine (DBSM)
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 60-minute training discusses common co-occurring medical conditions associated with AUD including liver disease, infectious diseases, respiratory illness, cardiovascular disease, and renal disease. It will discuss adjustments to MAUD necessary when patients present with one or more of these co-morbid conditions.
AUD Psychopharmacology in those with Co-morbid Medical Conditions
Host: American Academy of Addiction Psychiatry
Recorded: August 5, 2026
Enduring TrainingOverview
This training discusses common co-occurring medical conditions associated with alcohol use disorder (AUD), including liver disease, infectious diseases, respiratory illness, cardiovascular disease, and renal disease. Participants will learn to recognize the signs and symptoms of these co-occurring conditions and understand how medications for alcohol use disorder (MAUD) may need to be adjusted accordingly. The training explores updated, evidence-based guidance on key pharmacologic contraindications, dosing considerations, and medication adjustments. It also reviews medication metabolism mechanisms and the effects of MAUD on the immune system.
The target audience for this intermediate level activity includes: Prescribers
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Discuss the common, serious medical co-morbidities encountered in those with AUD.
- Understand how to modify use of medications for AUD (MAUD) in the face of serious medical co-morbidities.
- Describe effects of MAUD on medical co-morbidities.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Kevin Sevarino, MD, PhD (DFAAAP, FASAM, FAPA)
Medical Director
American Academy of Addiction Psychiatry (AAAP)
No Relevant Financial Disclosures.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 60-minute training explores the impact of alcohol on the hematologic system, examining how alcohol use can disrupt blood cell production and function. Participants will learn about alcohol-related bone marrow toxicity, impaired nutrient absorption, increased bleeding risk, compromised immune function, and other clinical complications affecting overall health and well-being.
Beyond the Liver: Understanding Alcohol’s Impact on Hematologic Function
Host: The National Council on Mental Wellbeing
Recorded: August 4, 2026
Enduring TrainingOverview
This training explores how alcohol disrupts blood cell production and function, including bone marrow toxicity, impaired nutrient absorption, increased bleeding risk, and increased vulnerability to infection. Because clinicians frequently encounter these hematologic abnormalities without a clear underlying cause, understanding alcohol's role can improve diagnosis, inform treatment decisions, and support more effective patient management. Participants will learn how alcohol affects blood cells and platelets, recognize common hematologic complications associated with alcohol use, and apply these insights to enhance clinical assessment and care.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Identify how alcohol affects red cells, white cells, and platelets.
- Recognize common hematologic complications linked to alcohol use.
- Apply clinical insights to improve patient assessment and management.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Thomas G. DeLoughery, M.D., M.A.C.P., FAWM
Oregon Health & Science University
Tom DeLoughery graduated from Indiana State University in 1981 and the Indiana University School of Medicine in 1985. He did his internship at the University of California, Irvine before traveling to Oregon where he finished his internal medicine residency and hematology/oncology fellowship.
He is currently a professor of medicine, pathology and pediatrics in the Divisions of Hematology/Oncology and Laboratory Medicine at OHSU. His clinical interests are in blood diseases, hemostasis, and thrombosis. He has won numerous teaching awards and has given education sessions to national meetings of many professional societies. He is the course director for the medical school Blood Course and was a co-developer of the Blood and Host Defense course for the New Curriculum.
He also has an interest in the hematologic aspects of sport and travel medicine and served six years on the board of directors of the Wilderness Medicine Society and has chaired their research committee. He is a master at the American College of Physicians and Fellows of the Academy of Wilderness Medicine.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 60 minute training discusses the pharmacology of GLP-1 medications and examine the growing body of research investigating their impact on alcohol cravings and recovery outcomes.
Injecting Hope - GLP-1 Receptor Agonists for the Treatment of Alcohol Use Disorder
Host: American Academy of Addiction Psychiatry
Recorded: July 29, 2026
Enduring TrainingOverview
This training explores the pharmacology of GLP-1 medications and examine the growing body of research investigating their impact on alcohol cravings and recovery outcomes. Participants will review emerging evidence supporting the use of GLP-1s for alcohol use disorder, while also considering important clinical questions, limitations, and concerns surrounding their use in this evolving area of addiction treatment.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Medical Knowledge, Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Describe the pharmacology of GLP-1 receptor agonists
- Evaluate the emerging evidence base to support their use in treatingsubstance use disorders
- Outline concerns being raised surrounding the use of GLP1s for SUD
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Joji Suzuki, MD
Dr Suzuki is the Director of the Division of Addiction Psychiatry in the Department of Psychiatry, Brigham and Women’s Hospital (BWH), and an Assistant Professor of Psychiatry at Harvard Medical School (HMS). He has been a consultation-liaison psychiatrist in the Division of Medical Psychiatry at BWH, and serves as the Program Director for the BWH Addiction Medicine Fellowship Program. He has been very active in both medical student and resident education throughout his career. He is a member of Motivational Interviewing Network of Trainers and is the course director for the HMS CME course on motivational interviewing. His research has received funding from National Institute on Drug Abuse (NIDA), CDC, SAMHSA, BWH, and HMS. In 2018 he was awarded a NIDA K23 Career Development Award to receive mentored training in conducting clinical trials, and to study the impact of recovery coaches on hospitalized patients with opioid use disorder. He is a sought-out speaker both locally and nationally, and currently serves on a variety of committees, workgroups, and taskforces for Mass General Brigham, HMS, American Academy of Addiction Psychiatry, Academy of Consultation Liaison Psychiatry, and the State of Massachusetts. He has published 80 manuscripts and book chapters as first or co-author.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 3 Component(s), Includes Credits
This 30-minute training discusses stigma surrounding medications for alcohol use disorder (MAUD) and recovery pathways can influence care experiences and treatment decisions.
Stigma Associated with MAUD within the Peer Recovery Community
Host: The National Council on Mental Wellbeing
Recorded: July 7, 2026
Enduring TrainingOverview
This training will help participants better understand how stigma surrounding medications for alcohol use disorder (MAUD) and recovery pathways can influence care experiences and treatment decisions. Through real-world case examples, learners explore the impact of both internalized and external stigma on individuals seeking recovery, examine the role of MAUD as an evidence-based treatment option for AUD, and identify practical approaches to fostering more inclusive and supportive recovery environments. Participants will leave with actionable strategies to promote person-centered care and support diverse pathways to recovery, particularly within peer recovery communities.
The target audience for this introductory level activity includes: All types of healthcare professionals.
The ACGME Competencies include: Patient Care and Procedural Skills, and Systems-based Practice
Learning Objectives
Upon completion, learners will be able to:
- Identify how various forms of stigma (both internalized and external) impact treatment engagement, and manifest within peer recovery communities.
- Explain the role of Medication for Alcohol Use Disorder (MAUD) in treating alcohol use disorder.
- Formulate practical strategies to support all-encompassing recovery pathways, specifically focusing on how to preempt and respond to stigma against MAUD in peer recovery settings.
- Registration Deadline: 08/30/2027
- Close Access Date: 09/30/2027
Instructions
- Click on the Contents tab to begin this activity.
- Click View On-Demand Session to watch the training.
- Click Complete GPRA Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click Claim Certificate of Completion to view/print certificate.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Nicole Tierney, JD
Licensed Professional Counselor; Licensed Clinical Alcohol and Drug Counselor; Certified Peer Recovery Specialist; Certified Recovery Support Practitioner, CPC Integrated Health
Mona Lisa McEachin, CRPA, CRPA-F, NYCPS, FPA-P
Assistant Program Director, Recovery Community and WNY Peer Workforce Development Center, BestSelf Behavioral Health Inc.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
This activity is not for credit.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 15 Component(s), Includes Credits
This 4.75-hour curriculum provides the foundational and introductory knowledge needed for peer recovery specialists (CPRS, PRSS) and other peer support roles who support individuals with alcohol use disorder (AUD).
Peer Recovery Specialists: Introductory Curriculum on Alcohol Use Disorder
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for peer recovery specialists (CPRS, PRSS) and other peer support roles who support individuals with alcohol use disorder (AUD), this curriculum provides the foundational knowledge needed to deliver high‑quality, person‑centered, recovery‑oriented AUD support.
The target audience for this introductory level activity includes peer recovery specialists (CPRS, PRSS) and other peer support roles.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
- Describe the risks and harms associated with alcohol use.
- Discuss the role of peer support specialists in supporting patients with alcohol use disorder.
- Identify different pathways for recovery and referral sources for patients with alcohol use disorder.
Registration Deadline: 04/25/2029
Close Access Date: 05/25/2029
Instructions
- Click on the Contents tab to begin this activity.
- Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
- Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
- Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete GPRA Survey to provide valuable activity feedback.
- Click Complete Evaluation and Complete Evaluation - Presenters to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Ed Salsitz
Dr. Salsitz is an Associate Clinical Professor of Psychiatry and is board-certified in addiction medicine by the American Board of Preventive Medicine. He received his MD from the SUNY Buffalo School of Medicine in 1972, and trained in internal medicine and did a fellowship in pulmonary disease at Beth Israel Medical Center.
He has been practicing addiction medicine for the past 35 years, and was the PI on an office-based methadone maintenance treatment research protocol, which was a unique paradigm for delivering opioid agonist therapy. He is an active member of the American Society of Addiction Medicine (ASAM), and has chaired and been a faculty member on numerous ongoing courses sponsored by ASAM. Dr. Salsitz has taught the buprenorphine waiver training course since 2003, and is a lead mentor in the Providers Clinical Support System (PCSS).
Dr. Salsitz specializes in all aspects of addiction medicine. Of late there has been an emphasis on opioid use disorder, as the opioid epidemic continues to worsen. He is particularly interested in the impact of fentanyl on the entire substance use disorder field. His clinical focus is on the evaluation and treatment of substance use disorders. He has an active teaching portfolio which includes the third year medical students, the PGY-2 psychiatric residents at MSH and MSBI, the PhD students in neuroscience, the master degree in science students, and trainings for ED residents and attendings. He teaches the buprenorphine courses and the REMS course for proper opioid prescribing under the auspices of ASAM. He also teaches third year medical students about addiction during their psychiatry clerkship.
Phil Owen
Peer Recovery Program Manager
Communities for Recovery
- Founder of Austin Area Opioid Workgroup
- Subject matter expert for the Peer Recovery Center of Excellence
- Recovery Support Peer Specialist and Supervisor at Communities for Recovery playing a pivotal role in developing and implementing programs to support individuals on their recovery journey.
- Peer Recovery Support Specialist trainer since 2018, playing a crucial role as writer for the Texas Recovery Support Peer Specialist 2024 curriculum
- Areas of expertise include strategies to reduce the risk of harm, peer supervision, and workforce development.
Patsy Dolan, LCSW
Executive Director
SIMS Foundation
Patsy Dolan Bouressa is a Licensed Clinical Social Worker Supervisor with over 20 years of experience as a counselor, including over 9 years’s experience working specifically with individuals in the music industry and their partners and other gig workers. Throughout her career, she’s worked extensively with clients facing the unique challenges of career transitions, depression, anxiety, substance use disorder, and trauma.
Itai Danovitch, MD, MBA, FAPA, DFASAM
Psychiatrist
Cedars Sinai
Itai Danovitch, MD, MBA is Professor and Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center in Los Angeles, California. Dr. Danovitch’s clinical practice and research focuses on substance use disorders, as well as the integration of medical and mental health services. His studies are funded by the National Institutes of Health (NIH).
Dr. Danovitch is the author of over 90 articles and book chapters and co-editor of two books on substance use disorders. He is a Distinguished Fellow of the American Society of Addiction Medicine, a Distinguished Fellow of the American Psychiatric Association, past president of the California Society of Addiction Medicine, and a recipient of the Golden Apple Award for Excellence in Teaching.Does Disclose: Bexson Biomedical: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)|Workit Health: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing)
Robin Landwehr, LPCC
Integrated Care Director
Spectra Health
Robin Landwehr holds a doctoral degree in Behavioral Health from Arizona State University, a master’s degree in Mental Health Counseling from Capella University, and is a Licensed Professional Counselor in North Dakota and a Licensed Mental Health Counselor in Florida. She is also a National Certified Counselor through the National Board for Certified Counselors.
Marlene Martin, MD
Professor
University of California, San Francisco
Marlene Martin, MD, is a Professor of Clinical Medicine at UCSF, Founding Director of the nationally recognized Addiction Care Team (ACT) at San Francisco General Hospital (ZSFG), Physician Chief of Care Experience at ZSFG, and Director of Addiction Initiatives for the UCSF Latinx Center of Excellence. She is committed to transforming systems of care to improve health outcomes for marginalized communities and ensuring that care is compassionate, accessible, and equitable.
No Relevant Financial Disclosures
Brian Fuehrlein, MD, PhD
Associate Professor Psychiatry
Yale School of Medicine
Dr. Fuehrlein graduated from the M.D. Ph.D. program at the University of Florida in 2008, adult psychiatry residency program at the University of Texas Southwestern Medical Center in 2012 and addiction psychiatry fellowship at Yale University in 2013. He is currently an Associate Professor and the director of the psychiatric emergency room at the VA Connecticut. Dr. Fuehrlein has a strong interest in medical student and resident education, particularly surrounding addiction psychiatry and serves on multiple local and national committees in this role. In 2017 he was awarded the Irma Bland award for excellency in psychiatry resident education through the APA. In 2018 he was awarded the Clerkship Faculty Teaching Award for Outstanding Medical Student Educator and Role Model. He is also passionate about emergency psychiatry and substance use disorders and has presented and published his work surrounding opioid use disorder in the emergency room setting. In 2019 he was inducted into the American College of Psychiatrists, an organization that recognizes excellence in clinical practice, research, academic leadership, or teaching.
No Relevant Financial Disclosures.
Accreditation & Credits
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
- NAADAC: 4 CE Credits
- Certified Counselors: NBCC Contact Hours not offered
American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
See the attached pdf for a list of disclosures.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information
-
Contains 14 Component(s), Includes Credits
This 5.25-hour curriculum provides the foundational and introductory knowledge needed for pharmacists (PharmDs and RPhs).
Pharmacists: Introductory Curriculum on Alcohol Use Disorder and Medications for Alcohol Use Disorders
Created by: American Society of Addiction Medicine
June 2026
Overview
Designed for pharmacists (PharmDs and RPhs) who support the treatment of alcohol use disorder (AUD) and medications for alcohol use disorder (MAUD), this curriculum provides the foundational knowledge needed to optimize medication‑related AUD care.
The target audience for this introductory level activity includes clinical healthcare professionals who prescribe medications in outpatient or inpatient settings.
This activity addresses the following ACGME Competencies: Patient Care and Procedural Skills; Medical Knowledge; Interpersonal and Communication Skills; and Systems-Based Practice
Learning Objectives
Upon completion, learners will be able to:
- Determine the most suitable FDA-approved medication to treat alcohol use disorder based on the patient’s clinical presentation and treatment goals.
- Discuss clinical considerations for prescribing medications to treat alcohol use disorder to patients with comorbid conditions.
- Recognize signs, symptoms, and risks factors for alcohol withdrawal syndrome.
Registration Deadline: 04/25/2029
Close Access Date: 05/25/2029
Instructions
- Click on the Contents tab to begin this activity.
- Click the first section, Screening, Goal Setting, & Conversations About Alcohol Use. On the first component, Digital Resource- Alcohol Use Disorder: Understanding Stigmatizing Language, click Download Digital Resource to get started.
- Expand and click each of the curriculum sections and components to review the enduring trainings, online modules, downloadable digital resources, and mini videos.
- Once you've reviewed all sections, click Post-Test, Evaluation & Claim Credit section.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
- Click Complete GPRA Survey to provide valuable activity feedback.
- Click Complete Evaluation and Complete Evaluation - Presenters to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.
- For Pharmacists ONLY: Complete the task entitled "Enter Pharmacist CPE Monitor Information (Pharmacists Only)". Pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist CPE Monitor Information survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information.
Need Assistance?
For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page, or contact [email protected].
Note for pharmacists: For courses offering CPE Credit, pharmacists must claim credit and provide their eProfile ID and Birthdate via the Pharmacist Survey within 30 days of completing the activity. ASAM will not report CPE Credits claimed 30+ days after activity completion to ACPE. ASAM will not report CPE Credits without accurate and complete information. Courses offering CPE Credit will indicate the amount of credit available for pharmacists on the Credits & Disclosure Tab.
Alyssa Falleni
PharmD
Alyssa Falleni, PharmD, is a clinical pharmacist who received her Doctorate of Pharmacy from the University of Rhode Island. She recently completed a two-year fellowship in Health Professions Education, Evaluation, and Research in Substance Use Disorders and Related Harms at the VA Connecticut Healthcare System. She holds a clinical instructor appointment at the Yale School of Medicine in the Department of Psychiatry and works as an outpatient HIV Pharmacist at Hartford Healthcare, Connecticut. Her research and clinical interests are in improving medication access for people who use substances and identifying and addressing social determinants of health.
No Relevant Financial Disclosures.
Joshua Lee, MD, MSc
Joshua D. Lee MD, MSc is a Professor in the departments of Population Health and Medicine/General Internal Medicine and Clinical Innovation at the NYU Grossman School of Medicine. He is Director of the NYU Fellowship in Addiction Medicine and Co-Director of DPH’s Section on Tobacco, Alcohol, and Drug Use. He is a clinician-researcher focused on addiction pharmacotherapies in primary care and criminal justice populations and leads the NYUGSOM Hub of the NIDA Justice and Community Opioid Innovation Network. He is a Science Advisor at Oar Health, an alcohol treatment provider.
Dislcosures: Indivior, in-kind study drug donation; Alkermes, in-kind study drug donation; Oar Health, Clinical Advisor
Lara Ray
PhD
Dr. Lara Ray received her PhD in Clinical Psychology from the University of Colorado at Boulder. Dr. Ray completed a predoctoral clinical internship at Brown University Medical School, where she stayed for a postdoctoral fellowship at the Brown University Center for Alcohol and Addiction Studies. After her postdoctoral fellowship, Dr. Ray joined the faculty at the UCLA Clinical Psychology Program, where she is now a Full Professor. Dr. Ray also has academic appointments at the UCLA Department of Psychiatry and Human Behavior and the UCLA Brain Research Institute. Dr. Ray has an active program of research on the clinical neuroscience of addiction. Her laboratory combines experimental psychopharmacology with behavioral genetic and neuroimaging methods to ascertain the mechanisms underlying addictive disorders in humans and apply these insights to treatment development. Dr. Ray has over 250 peer-reviewed publications and book chapters. Her program of research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) as well as the National Institute on Drug Abuse (NIDA). Dr. Ray has received research excellence awards from the American Psychological Association (APA), the Research Society on Alcoholism (RSA), and the American College on Neuropsychopharmacology (ACNP).
No Relevant Financial Disclosures.
Melissa Weimer, Do, MCR, DFASAM
PCSS-MAUD Medical Director
Yale School of Medicine
Lamia Haque, MD, MPH
Hepatologist, Addiction Medicine Specialist, Assistant Professor of Internal Medicine
Yale School of Medicine
No relevant financial disclosures
Julie Byler, D.O., FASAM
Adventist Improving Addiction Care Team (IMPACT) Lead
Adventist Health Portland
No Relevant Financial Disclosures
Tessa Steel
MD, MPH
Tessa Steel, MD, MPH is an Assistant Professor, physician-scientist, and Pulmonary Critical Care Medicine doctor at Harborview Medical Center, a county safety-net hospital operated by the University of Washington in Seattle. She is board-certified in Internal Medicine, Pulmonary Medicine, and Critical Care Medicine. Her clinical and research interests include improving hospital-based treatments for alcohol withdrawal syndrome and using hospitalizations to help people with addiction launch their process of recovery.
No Relevant Financial Disclosures.
Stephen Holt
MD, MS, FACP
Accreditation & Credits
Joint Accreditation Statement
In support of improving patient care, the American Society of Addiction Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credits Available
- Pharmacists: 5.25 Credits
- Certified Counselors: NBCC Contact Hours Not Offered American Society of Addiction Medicine has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7062. Programs that do not qualify for NBCC credit are clearly identified. American Society of Addiction Medicine is solely responsible for all aspects of the programs.
- NAADAC: CE Credits not offered
Certificates for other professions
All participants may request a certificate of participation upon completion of the activity and an online evaluation confirming their participation. Learners are strongly advised to contact their professional licensing board or professional association to confirm this certificate will be accepted as evidence supporting continuing education requirements.
Disclosure Information
In accordance with the disclosure policies of ASAM and Joint Accreditation, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all accredited continuing education activities. These policies include identifying and mitigating all relevant financial relationships with ineligible companies for those involved in the creation and dissemination of accredited continuing education.
See the attached pdf for a list of disclosures.
-
Register
- Administrative Staff - Free!
- Counselor (CAADE, CADTP, CCAPP, LPC, LMHC NCC, etc.) - Free!
- PhD - Free!
- Nurse (MSN, LPN, RN, LVN) - Free!
- Nurse Practitioner (APRN, DNP) - Free!
- Pharmacist (PharmD) - Free!
- Physician (MD) - Free!
- Physician (DO) - Free!
- Physician (MBBS) - Free!
- Physician Associate (PA-C) - Free!
- Psychologist (PsyD) - Free!
- Social Worker (MSW, LCSW, LGSW) - Free!
- Student/Resident/Fellow - Free!
- Other - Free!
- More Information